VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 127 filers reported holding VOYAGER THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $96,992 | -81.3% | 12,580 | -53.7% | 0.00% | -85.7% |
| Q1 2019 | $520,000 | +103.1% | 27,190 | 0.0% | 0.01% | +75.0% |
| Q4 2018 | $256,000 | -50.2% | 27,190 | 0.0% | 0.00% | -42.9% |
| Q3 2018 | $514,000 | +81.0% | 27,190 | +86.9% | 0.01% | +75.0% |
| Q2 2018 | $284,000 | +120.2% | 14,544 | +1.0% | 0.00% | +100.0% |
| Q2 2017 | $129,000 | +79.2% | 14,394 | +163.0% | 0.00% | +100.0% |
| Q1 2017 | $72,000 | -22.6% | 5,473 | -24.7% | 0.00% | 0.0% |
| Q4 2016 | $93,000 | – | 7,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $120,921,000 | 54.00% |
| Trustees of Princeton University | 203,632 | $3,853,000 | 5.43% |
| GREAT POINT PARTNERS LLC | 1,400,000 | $26,488,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $21,474,000 | 2.61% |
| ARMISTICE CAPITAL, LLC | 1,724,000 | $32,618,000 | 1.96% |
| BB BIOTECH AG | 2,822,641 | $53,404,000 | 1.41% |
| HARBOURVEST PARTNERS LLC | 72,726 | $1,376,000 | 1.24% |
| Aevitas Wealth Management, Inc. | 62,323 | $1,179,000 | 1.07% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,001,870 | $18,955,000 | 0.88% |
| Patriot Financial Group Insurance Agency, LLC | 60,586 | $1,146,000 | 0.68% |